The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation
FDA Law Blog
SEPTEMBER 29, 2021
A growing list of drug manufacturers are claiming that the discounts meant for low-income patients of 340B covered entities are instead contributing to profits for pharmacies that contract with covered entities to dispense 340B drugs. HRSA based its opinion on the statute and agency precedents over the last 25 years.
Let's personalize your content